Veterinary medicine is a branch of medicine that deals with prevention, management, diagnosis, and treatment of disease, disorder, and injury in animals (both companion animals and livestock animals). Moreover, veterinary drugs indirectly benefit human healthcare by restricting the spread of infectious diseases from animals to humans. Therefore, there is an increasing demand for safe and effective veterinary drugs around the world.
Rising incidence of zoonotic diseases, increase in pet ownership, increase in demand for meat and animal-based products, rise in demand for veterinary medicine, and rise in focus on the veterinary healthcare are major factors expected to drive growth of the global veterinary medicinemarket.
For instance, in September 2022, the Food and Drug Administration (FDA) approved SpectoGard, the first generic spectinomycin sulfate injectable solution for the treatment of bovine respiratory diseases. Moreover, in September 2022, the US FDA approved Simplera Otic Solution, one of the first generic drug products that have a single-dose treatment with a 30-day duration of effect for otitis externa (outer ear infection) in dogs.
- This report provides in-depth analysis of the veterinary medicinemarket, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global veterinary medicinemarket based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Ceva, Zoetis, Elanco, Chanelle Pharma Group, and Boehringer Ingelheim International Gmbh, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global veterinary medicinemarket report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary medicinemarket.
-
-
-
-
- Veterinary Hospitals & Clinics
- Retail Stores
- Online Pharmacies
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Ceva
- Zoetis
- Elanco
- Chanelle Pharma Group
- Boehringer Ingelheim International Gmbh
